Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription Articles published in Br J Psychiatry Retrieve available abstracts of 58 articles: HTML format

Single Articles

August 2024
1. LIU R, Li D, Ma Y, Tang L, et al
   Air pollutants, genetic susceptibility and the risk of schizophrenia: large prospective study.
   Br J Psychiatry. 2024 Aug 9:1-9. doi: 10.1192/bjp.2024.
   PubMed     Abstract available
   
   
   
2. KIKUCHI Y, Kurosawa M, Sakata M, Takahashi Y, et al
   Effects of titration speed, gender, obesity and concomitant medications on the risk and onset time of clozapine-associated fever among Japanese patients with schizophrenia: retrospective review of charts from 21 hospitals.
   Br J Psychiatry. 2024 Aug 6:1-7. doi: 10.1192/bjp.2024.
   PubMed     Abstract available
   
   
   
3. FAROOQ S, Hattle M, Kingstone T, Ajnakina O, et al
   Development and initial evaluation of a clinical prediction model for risk of treatment resistance in first-episode psychosis: Schizophrenia Prediction of Resistance to Treatment (SPIRIT).
   Br J Psychiatry. 2024 Aug 5:1-10. doi: 10.1192/bjp.2024.
   PubMed     Abstract available
   
   
   
4. SHERGILL SS, Meshreky KM
   Towards a unified theory of the aetiology of schizophrenia: commentary, Shergill et al.
   Br J Psychiatry. 2024 Aug 5:1-2. doi: 10.1192/bjp.2024.
   PubMed    
   
   
   July 2024
5. HUANG ML, Wei LC
   Psychological framework to understand interpersonal violence by forensic patients with psychosis: commentary, Huang & Wei.
   Br J Psychiatry. 2024 Jul 31:1. doi: 10.1192/bjp.2024.
   PubMed    
   
   
   May 2024
6. CHEN PH, Tsai SY, Chen PY, Pan CH, et al
   Lipid-modifying agents and risk of all-cause, natural and suicide mortality in schizophrenia: nationwide cohort study.
   Br J Psychiatry. 2024 May 16:1-9. doi: 10.1192/bjp.2024.
   PubMed     Abstract available
   
   
   
7. FREEMAN D
   Developing psychological treatments for psychosis.
   Br J Psychiatry. 2024;224:147-149.
   PubMed     Abstract available
   
   
   
8. FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
   The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
   Br J Psychiatry. 2024;224:164-169.
   PubMed     Abstract available
   
   
   April 2024
9. QI R, Qureshi M, Gire N, Chaudhry IB, et al
   Ethnic density and first episode psychosis in the British Pakistani population: findings from the East Lancashire Early Intervention Service.
   Br J Psychiatry. 2024 Apr 18:1-6. doi: 10.1192/bjp.2024.
   PubMed     Abstract available
   
   
   March 2024
10. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium - CORRIGENDUM.
    Br J Psychiatry. 2024 Mar 18:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    February 2024
11. HASSIOTIS A, Noor M, Bebbington P, Ali A, et al
    Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence - CORRIGENDUM.
    Br J Psychiatry. 2024 Feb 13:1. doi: 10.1192/bjp.2024.
    PubMed    
    
    
    January 2024
12. MCCUTCHEON RA, Cannon A, Parmer S, Howes OD, et al
    How to classify antipsychotics: time to ditch dichotomies?
    Br J Psychiatry. 2024;224:20-25.
    PubMed     Abstract available
    
    
    November 2023
13. SAHIN D, Kambeitz-Ilankovic L, Wood S, Dwyer D, et al
    Algorithmic fairness in precision psychiatry: analysis of prediction models in individuals at clinical high risk for psychosis.
    Br J Psychiatry. 2023 Nov 8:1-11. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    October 2023
14. LAMBE S, Cooper K, Fazel S, Freeman D, et al
    Psychological framework to understand interpersonal violence by forensic patients with psychosis.
    Br J Psychiatry. 2023 Oct 20:1-8. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
15. KOHLER-FORSBERG O, Ge F, Hauksdottir A, Thordardottir EB, et al
    Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study.
    Br J Psychiatry. 2023 Oct 18:1-7. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
16. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Br J Psychiatry. 2023;223:485-492.
    PubMed     Abstract available
    
    
    August 2023
17. JIN H, Kolawole O, Wang Z
    Cost-effectiveness analysis of physical activity interventions for people with schizophrenia or bipolar disorder: systematic review.
    Br J Psychiatry. 2023;223:362-376.
    PubMed     Abstract available
    
    
    
18. KELLEHER I
    Author's Reply. RE: Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023;223:394-395.
    PubMed    
    
    
    
19. GRIFFITHS SL, Brown L, Kirkbride JB
    RE: Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023;223:394.
    PubMed    
    
    
    July 2023
20. FERNANDEZ-EGEA E, Mucci A, Lee J, Kirkpatrick B, et al
    A new era for the negative symptoms of schizophrenia.
    Br J Psychiatry. 2023;223:269-270.
    PubMed     Abstract available
    
    
    
21. AYMERICH C, Catalan A, Salazar de Pablo G
    RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023;223:336.
    PubMed    
    
    
    
22. KIRKPATRICK B, Luther L, Strauss GP
    Negative symptoms in the clinic: we treat what we can describe.
    Br J Psychiatry. 2023;223:271-272.
    PubMed     Abstract available
    
    
    
23. WOLPE N, Chen S, Kirkpatrick B, Jones PB, et al
    Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023;223:336-337.
    PubMed    
    
    
    
24. CHEN EYH, Wong SMY, Hui CLM, Suen YN, et al
    The emergence of primary negative symptoms: relevance of timing?
    Br J Psychiatry. 2023;223:280-281.
    PubMed     Abstract available
    
    
    June 2023
25. HOWES O, Fusar-Poli P, Osugo M
    Treating negative symptoms of schizophrenia: current approaches and future perspectives.
    Br J Psychiatry. 2023 Jun 5:1-4. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
26. BYNG R, Creanor S, Jones B, Hosking J, et al
    The effectiveness of a primary care-based collaborative care model to improve quality of life in people with severe mental illness: PARTNERS2 cluster randomised controlled trial.
    Br J Psychiatry. 2023;222:246-256.
    PubMed     Abstract available
    
    
    
27. NORTHWOOD K, Pearson E, Arnautovska U, Kisely S, et al
    Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis.
    Br J Psychiatry. 2023;222:241-245.
    PubMed     Abstract available
    
    
    May 2023
28. GALDERISI S, Kaiser S
    The pathophysiology of negative symptoms of schizophrenia: main hypotheses and open challenges.
    Br J Psychiatry. 2023 May 26:1-3. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
29. PENADES R, Wykes T
    Use of cognitive remediation to treat negative symptoms in schizophrenia: is it time yet?
    Br J Psychiatry. 2023 May 17:1-2. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    
30. SALAZAR DE PABLO G, Catalan A, Vaquerizo Serrano J, Pedruzo B, et al
    Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.
    Br J Psychiatry. 2023 May 17:1-13. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    March 2023
31. CELLA M, Roberts S, Pillny M, Riehle M, et al
    Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses.
    Br J Psychiatry. 2023 Mar 15:1-11. doi: 10.1192/bjp.2023.
    PubMed     Abstract available
    
    
    January 2023
32. KELLEHER I
    Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023 Jan 12:1-3. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    
33. WOLPE N, Chen S, Kirkpatrick B, Jones PB, et al
    Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023 Jan 10:1-3. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    
34. O'BRIEN KJ, Ered A, Korenic SA, Olino TM, et al
    Childhood trauma, perceived stress and anhedonia in individuals at clinical high risk for psychosis: multigroup mediation analysis.
    Br J Psychiatry. 2023 Jan 5:1-7. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    December 2022
35. AHANGARI M, Bustamante D, Kirkpatrick R, Nguyen TH, et al
    Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia.
    Br J Psychiatry. 2022 Dec 12:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    
36. IKKOS G, Stanghellini G
    Sensibility and schizophrenia: Wilhelm Waiblinger on Friedrich Holderlin's life, poetry and madness - psychiatry in literature.
    Br J Psychiatry. 2022;221:739.
    PubMed    
    
    
    
37. BUTLER E, Pillinger T, Brown K, Borgan F, et al
    Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study.
    Br J Psychiatry. 2022;221:740-747.
    PubMed     Abstract available
    
    
    November 2022
38. WATSON AJ, Harrison L, Preti A, Wykes T, et al
    Cognitive trajectories following onset of psychosis: a meta-analysis - CORRIGENDUM.
    Br J Psychiatry. 2022 Nov 14:1. doi: 10.1192/bjp.2022.
    PubMed    
    
    
    September 2022
39. WATSON AJ, Harrison L, Preti A, Wykes T, et al
    Cognitive trajectories following onset of psychosis: a meta-analysis.
    Br J Psychiatry. 2022 Sep 23:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    August 2022
40. LAHTEENVUO M, Luykx JJ, Taipale H, Mittendorfer-Rutz E, et al
    Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts.
    Br J Psychiatry. 2022 Aug 25:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    July 2022
41. FLEETWOOD K, Wild SH, Smith DJ, Mercer SW, et al
    Association of severe mental illness with stroke outcomes and process-of-care quality indicators: nationwide cohort study.
    Br J Psychiatry. 2022;221:394-401.
    PubMed     Abstract available
    
    
    May 2022
42. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make? - CORRIGENDUM.
    Br J Psychiatry. 2022 May 23:1. doi: 10.1192/bjp.2022.
    PubMed    
    
    
    April 2022
43. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make?
    Br J Psychiatry. 2022 Apr 6:1-3. doi: 10.1192/bjp.2021.
    PubMed     Abstract available
    
    
    February 2022
44. ANTONUCCI LA, Penzel N, Sanfelici R, Pigoni A, et al
    Using combined environmental-clinical classification models to predict role functioning outcome in clinical high-risk states for psychosis and recent-onset depression.
    Br J Psychiatry. 2022 Feb 14:1-17. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    
45. CUI Y, Li C, Liu B, Sui J, et al
    Consistent brain structural abnormalities and multisite individualised classification of schizophrenia using deep neural networks.
    Br J Psychiatry. 2022 Feb 11:1-8. doi: 10.1192/bjp.2022.
    PubMed     Abstract available
    
    
    January 2022
46. LEE R, Leighton SP, Thomas L, Gkoutos GV, et al
    Prediction models in first-episode psychosis: systematic review and critical appraisal.
    Br J Psychiatry. 2022 Jan 24:1-13. doi: 10.1192/bjp.2021.
    PubMed     Abstract available
    
    
    December 2021
47. XI YB, Wu XS, Cui LB, Bai LJ, et al
    Neuroimaging-based brain-age prediction of first-episode schizophrenia and the alteration of brain age after early medication.
    Br J Psychiatry. 2021 Dec 2:1-8. doi: 10.1192/bjp.2021.
    PubMed     Abstract available
    
    
    
48. BAKER SJ, Jackson M, Jongsma H, Saville CWN, et al
    The ethnic density effect in psychosis: a systematic review and multilevel meta-analysis.
    Br J Psychiatry. 2021;219:632-643.
    PubMed     Abstract available
    
    
    
49. BHUI K, Halvorsrud K, Mooney R, Hosang GM, et al
    Is psychosis a syndemic manifestation of historical and contemporary adversity? Findings from UK Biobank.
    Br J Psychiatry. 2021;219:686-694.
    PubMed     Abstract available
    
    
    
50. ELLETT L, Chadwick P
    Recommendations for monitoring and reporting harm in mindfulness for psychosis research.
    Br J Psychiatry. 2021;219:629-631.
    PubMed     Abstract available
    
    
    July 2021
51. MCDONALD K, Ding T, Ker H, Dliwayo TR, et al
    Using epidemiological evidence to forecast population need for early treatment programmes in mental health: a generalisable Bayesian prediction methodology applied to and validated for first-episode psychosis in England.
    Br J Psychiatry. 2021;219:383-391.
    PubMed     Abstract available
    
    
    
52. VAN DER MEER L, Kaiser S, Castelein S
    Negative symptoms in schizophrenia: reconsidering evidence and focus in clinical trials.
    Br J Psychiatry. 2021;219:359-360.
    PubMed     Abstract available
    
    
    
53. CASTELEIN S, Timmerman ME, van der Gaag M, Visser E, et al
    Clinical, societal and personal recovery in schizophrenia spectrum disorders across time: states and annual transitions.
    Br J Psychiatry. 2021;219:401-408.
    PubMed     Abstract available
    
    
    
54. ZHU Y, Wang S, Gong X, Edmiston EK, et al
    Associations between hemispheric asymmetry and schizophrenia-related risk genes in people with schizophrenia and people at a genetic high risk of schizophrenia.
    Br J Psychiatry. 2021;219:392-400.
    PubMed     Abstract available
    
    
    
55. BHATTACHERJEE S, Young A, Ahuja N, Allen S, et al
    Should intramuscular clozapine be adopted into mainstream clinical practice?
    Br J Psychiatry. 2021;219:357-358.
    PubMed     Abstract available
    
    
    May 2021
56. SISKIND D, Orr S, Sinha S, Yu O, et al
    Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
    Br J Psychiatry. 2021 May 11:1-6. doi: 10.1192/bjp.2021.
    PubMed     Abstract available
    
    
    October 2020
57. FOND G, Pauly V, Bege T, Orleans V, et al
    Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database.
    Br J Psychiatry. 2020;217:568-574.
    PubMed     Abstract available
    
    
    May 2020
58. OHI K, Shimada T, Kataoka Y, Yasuyama T, et al
    Genetic correlations between subcortical brain volumes and psychiatric disorders.
    Br J Psychiatry. 2020;216:280-283.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.